Biosimilars price point

Prices and savings potential of biosimilars

In principle, biosimilars offer a clear price advantage compared to the respective comparable preparations from the original manufacturers.  Biosimilars are 25 % cheaper when released onto the market than the corresponding biopharmaceutical formerly protected by a patent.  With the increasing spread of biosimilars, savings in the three-digit millions are realistic also in Switzerland.